Autor: |
Demirci, Umut, Coskun, Ugur, Erdem, Ozlem, Ozturk, Banu, Bilge Yilmaz, Isilay, Benekli, Mustafa, Buyukberber, Suleyman |
Předmět: |
|
Zdroj: |
Journal of Oncology Pharmacy Practice; Sep2011, Vol. 17 Issue 3, p285-287, 3p, 2 Color Photographs |
Abstrakt: |
Tyrosine kinase inhibitors (TKIs) are targeted treatments for various cancers. Skin toxicities are one of the most common nonhematological side-effects of TKIs. We report an imatinib mesylate (IM) induced hyperpigmented acne rosacea (AR) and sunitinib-induced palmar hyperkeratosis in the case with gastrointestinal stromal tumor. AR was arisen due to the discontinuation of IM. To the best of our knowledge, this kind of cutaneous side-effect with IM has not been documented previously. [ABSTRACT FROM PUBLISHER] |
Databáze: |
Complementary Index |
Externí odkaz: |
|